Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluAS25 versus Fluarix immunogenicity study in adults aged 50 years and older
2006-003238-14Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in influenza comparing FluAS25 with Fluarix (2 arms). Primary endpoints: Superior immune response in elderly adults versus Fluarix and Safety and reactogenicity. Started Aug 2006; status: completed.
02
Drugs
GSK576389AFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-003238-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003238-14.